SPRB

Conviction 8HealthcareScan · Mon, Jul 20, 2026

Bullish belt hold

SPRB$44.49+2.18%

ResistanceSupportVol 14

Vol MA14 71K

Apr 20May 6May 26Jun 11Jul 1Jul 20

SPRUCE BIOSCIENCES, INC.PHARMACEUTICAL PREPARATIONSwww.sprucebiosciences.com ↗

Price44.49

Change+2.18%

Gap-0.60%

Rel volume0.40×

Avg volume86.73K

Avg $ vol4.45M

SMA 2050.41

SMA 5051.17

SMA 20075.82

Price vs 50-13.06%

Price vs 200-41.32%

MA stackbearish

50/200 cross—

Supertrenddown · 53.58

RSI (14)36

MACD hist-0.82

MACD crossbear · 8d

Stoch %K / %D13 / 9

ADX (14)20

+DI / −DI10 / 24

RSI divergence—

MACD divergence—

ATR %+7.38%

ADR %6.27%

52w high182.60

52w low0.0786

From 52w high-75.64%

Above 52w low+56503.05%

New 52w highNo

SqueezeOff

Bollinger width29.29%

%B0.10

Donchian pos12.52%

Donchian high57.00

Donchian low42.70

AVWAP (52w high)103.11

vs AVWAP high-56.85%

AVWAP (52w low)82.13

vs AVWAP low-45.83%

OBV trendFlat

Chaikin MF (20)0.01

Today vs 20d0.40×

Avg vol (14d)71K

Avg vol (20d)86.73K

Avg $ vol (20d)4.45M

Market cap122.45M

RS 3m (vs SPY)-41.81%

RS 6m (vs SPY)-52.11%

RS line new highNo

Trend template2/8

Technical rank10.8

1 week-8.04%

1 month-8.76%

3 months-36.71%

6 months-40.59%

1 year+11337.02%

YTD-50.95%

P/E-3.14

P/B3.53

P/S—

P/FCF-3.67

EPS-50.83

Div yield—

ROE-112.46%

ROA-69.38%

Debt/Eq0.19

Current4.67

EV/EBITDA-2.05

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth26.53%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value74.83M

Revenue0

Net income-12.27M

Gross profit—

Free cash flow-33.33M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out2.75M

Employees8

ListedFri, Oct 9, 2020

Free float722.82K

Float %67.5%

Short interest359.39K

Days to cover3.1d

Short volume74.2%

Squeeze score76 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$8.94 vs −$7.32

Last surprise-22.1% miss

Setup gradeD

Conviction8 / 100

Pattern quality—

Tech rank10.8 / 100

Group rank23 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish belt hold

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SPRB

All disclosures →

No recent disclosed trades by Congress in SPRB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SPRB · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER · Common Stock · 2026-06-30	Grant	266	$1K	2026-06-30	2026-07-09
Walbert Keli Director · Stock Option (Right to Buy) · 2026-05-21	Grant	1.7K	$0	2026-05-21	2026-05-26
SIMPSON CAMILLA V Director · Stock Option (Right to Buy) · 2026-05-21	Grant	1.7K	$0	2026-05-21	2026-05-26
GREY MICHAEL G Executive Chairman · Stock Option (Right to Buy) · 2026-05-21	Grant	1.7K	$0	2026-05-21	2026-05-26
SPIEGELMAN DANIEL K Director · Stock Option (Right to Buy) · 2026-05-21	Grant	1.7K	$0	2026-05-21	2026-05-26
Barretto-Ko Percival Director · Stock Option (Right to Buy) · 2026-05-21	Grant	1.7K	$0	2026-05-21	2026-05-26

SEC filings

EDGAR filings in SPRB

EDGAR →

No recent SEC filings on file for SPRB.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.